In recent years, the treatment landscape for acromegaly, a rare endocrine disorder, has significantly evolved. Distinguishing among treatment modalities, their roles in therapy, and the patients most likely to benefit from each approach can be challenging. Determining when to initiate, switch, or combine therapies requires a deep understanding of each treatment, individual patient responses, and considerations for minimizing adverse effects. Different administration routes, including oral, injectable, and long-acting formulations, further contribute to the complexity of treatment decision-making. Tune in to this expert discussion to explore the latest data on disease-targeted therapies for acromegaly and evidence-based strategies to optimize personalized treatment and patient outcomes.
- Provider:PRIME Education, Inc. (PRIME®)
- Activity Link: https://primeinc.org/online/optimizing-personalized-treatment-decision-making-acromegaly-latest-data
- Start Date: 2024-03-15 05:00:00
- End Date: 2024-03-15 05:00:00
- Credit Details: AAPA Category 1 Credit™️: 0.25 hours
AMA PRA Category 1 Credit™️: 0.25 hours
Nursing: 0.25 hours
Pharmacy: 0.25 hours - Commercial Support: Source: Recordati Rare Disease Inc. - Amount: 24875.0 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all